If the proteins targeted by new drugs turn out to differ from one tumor to the next or to vary within a tumor during the course of its growth or treatment, this heterogeneity will make it difficult to get therapies that target blood vessels to work on the
详情正文
登录后查看完整内容
使用 DeepEvidence / 梅斯账号登录，新用户可在登录页面注册。
登录 / 注册登录成功后将返回当前页面，继续浏览。